LiveDrop microfluidic technology

LiveDrop offers cutting-edge microfluidic solutions that enhance antibody discovery and drug testing. With technologies like ModaFlow and OneFlow, they enable high-throughput screening while minimizing waste and promoting sustainability. Their commitment to responsible innovation makes them a leader in the field, bridging the gap between research and industry.

LiveDrop: Transforming Antibody Discovery and Drug Testing with Microfluidic Technology

What is ModaFlow and LiveDrop?

ModaFlow™ is an innovative droplet microfluidic device designed to revolutionize antibody discovery by enabling high-throughput screening of millions of individual cells encapsulated in picoliter droplets with unmatched precision. This technology slashes costs, boosts efficiency, and shortens discovery timelines, making it a game-changer in biomedical research. Alongside ModaFlow™, LiveDrop offers an integrated platform featuring OneFlow™ and ModaFlow™ that brings high-end benchtop solutions for single-cell and 3D cell culture droplet assays, bridging the gap between R&D and industrial applications. Together, they make droplet biology accessible and standardized across research and industry.

Main Benefits and Key Figures

LiveDrop and ModaFlow™ pack some serious punch when it comes to performance and flexibility. Here are the standout numbers that highlight their capabilities:

  • 10M+ Cells/hour: Advanced high-throughput encapsulation of biological materials, from single cells to spheroids, enabling massive screening capacity.
  • 0% Waste: Zero dead volume means 100% of the injected sample is processed—super important when working with rare or precious materials.
  • 100% Flexible: A highly adaptable platform that can run tens of different assays and workflows. The only limit? Your imagination.
  • 5 Colors: Full spectrum available for multiplex fluorescence screening, allowing complex and detailed analysis.

High-Throughput Spheroids and Organoids for Drug Testing

OneFlow™ technology enables rapid, consistent, and scalable production of 3D cell cultures like spheroids and organoids, which are essential for drug screening, regenerative medicine, and cancer research. It promotes cell aggregation and cell-cell interactions while ensuring uniform spheroid size, which boosts reproducibility and reliability in experiments. Using microfluidic droplet-based spheroid generation drastically cuts down processing time, minimizes cell and reagent consumption, and allows for high-throughput screening—accelerating biomedical research and therapeutic development like never before.

Collaborations Driving Innovation

Cellistic, a leader in advancing allogeneic cell therapy using induced pluripotent stem cells (iPSC), leverages state-of-the-art platforms like Pulse and Echo. To push their capabilities even further, they’ve teamed up with LiveDrop’s advanced microfluidic technology. This partnership perfectly aligns with their mission to make cell therapies more accessible and affordable, showcasing how cutting-edge tech can drive real-world impact.

Custom Assistance for Seamless Adoption

One of LiveDrop’s standout features is its commitment to helping scientists and biotech companies embrace droplet biology. Their expert team offers custom assistance to implement traditional methods into the droplet format, maximizing success rates and ensuring a smooth transition to this cutting-edge technology. This hands-on support makes adopting new workflows less daunting and more effective.

Project Impact on Sustainable Development Goals (SDGs)

  • SDG 3: Good Health and Well-being – by advancing drug testing and cell therapy technologies.
  • SDG 9: Industry, Innovation, and Infrastructure – through cutting-edge microfluidic platforms bridging research and industry.
  • SDG 12: Responsible Consumption and Production – minimizing waste with zero dead volume processing.
  • SDG 13: Climate Action – focusing on sustainability and reducing environmental impact.
  • SDG 15: Life on Land – by minimizing animal harm in research through advanced in vitro models.

Minimizing Environmental Impact and Promoting Sustainability

LiveDrop is not just about innovation—it’s about responsible innovation. The company prioritizes sustainability by reducing costs, minimizing environmental impact, and cutting down on animal harm. This approach sets new industry standards while pushing scientific research forward in a way that’s mindful of our planet and ethical considerations. It’s science with a conscience, making sure progress doesn’t come at a high environmental or moral price.

Discover other innovative projects :

Learn more about the Sustainable Development Goals :